Strategic Evaluation of Precision Medicine

Country Analysis for Emerging Opportunities

Published Year: 2018
SKU: BH00618SA


Online Access for 1-3 Users. Permission to Print.

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Table of Contents

Request a Sample

Precision Medicine: A Frontier in the Genesis of Patient-centric Medicine

     1.1   Precision Medicine:  Remodelling the One-Size-Fits-All  Theory to Individually-Tailored Therapy
     Figure 1.1   Evolution of Precision Medicine
     Figure 1.2   Global Market Share (by Precision Medicine Stakeholders) (2020)
     Figure 1.3   Precision Medicine: Remodelling the One-Size-Fits-All Theory to Individually-Tailored Therapy
     Figure 1.4   SWOT Analysis of Precision Medicine

Regional Strategy for Penetration and Implementation of Precision Medicine

      2.1   North America
      2.2   Europe
      2.3   Asia-Pacific
      Figure 2.1   Precision Medicine Market Size (2017 and 2026)
      Figure 2.2   North America Market Size (2016-2026)
      Figure 2.3   Europe Market Size (2016-2026)
      Figure 2.4   Asia-Pacific Market Size (2016-2026)

Best Practices Across the World (U.S., U.K., and China)

      Figure 3.1   Precision Medicine Market, Key Countries (2017)
      Figure 3.2   Notable Areas of Strategic Focus across Influential Countries

Augmenting the Growth by Realizing the Full Potential of Precision Medicine Technologies

      Figure 4.1   Notable Areas of Strategic Focus Across Influential Countries

The Eminent Stakeholders Aligning the Fortune of Precision Medicine

      5.1   Industrial Perspective Directing the Peaks and Valleys of Precision Medicine Market
      5.2   Organizations Reducing the Disparities in Healthcare System
      Figure 5.1   Total Addressable Market for Precision Medicine Stakeholders (2015-2026)
      Figure 5.2   Precision Medicine Funding for Academic Institutions and Research Organizations (2017)

Propitious Strategies for Succeeding in the Field of Precision Medicine

      6.1   Marketing and Promotion Strategies: To Provide an Edge in Highly Competitive Precision Medicine Market
      Figure 6.1   A Persuasive Market Entry Strategy for Diagnostics and Pharma & Biotech Companies to Capitalize on Precision Medicine
      Figure 6.2   Persuasive Market Entry Strategy for Healthcare IT to Capitalize on Precision Medicine
      Figure 6.3   Plausible Market Penetration Strategy to Shape the Future of Healthcare
      Figure 6.4   Go-to-Market Strategy with Innovative Tools and Technologies to Structure the Arena of Precision Medicine
      Figure 6.5   Value Assessment Frameworks
      Figure 6.6   Product/ Service Promotion Strategies
      Figure 6.7   Precision Medicine: A Trigger to Unfold Innovative Business Model

Realizing the Impact of Precision Medicine

      Figure 7.1   Potential Societal Value for Precision Medicine

You may also like

Published Year: 2018

Global Metastatic Cancer Treatment Market : Focus on Drugs, Competitive Landscape, and Country - Ana

The global metastatic cancer treatment market was valued $54.11 billion in 2017, and is...

Published Year: 2018

Global CRISPR Technology Market : Focus on Product, Applications, Geographical Analysis, Industry In

The global CRISPR technology market is expected to reach $10.55 billion by...

Published Year: 2017

Global Next Generation Sequencing (NGS) Market - Analysis and Forecast (2017-2024) : (Focus on Produ

(Focus on Product Type, Technology, Application, Country Analysis, Market Share Analysis,...

Published Year: 2017

Global Precision Medicine Market – Analysis and Forecast (2017-2026): (Focus on Ecosystem Player,

The global precision medicine market was dominated by the oncology segment in 2016. The...

Published Year: 2017

Global Liquid Biopsy Market - Analysis and Forecast, 2017-2025: (Focus on Product Type, Therapeutic

The global liquid biopsy market is anticipated to grow over $4,434 million by 2025. With the...


Strategic Evaluation of Precision Medicine

Country Analysis for Emerging Opportunities